Recombinant PDL1 (Adebrelimab Biosimilar) antibody

Catalog No. ABIN7597491

This Humanized Chimeric antibody specifically detects PDL1 (Adebrelimab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant PDL1 (Adebrelimab Biosimilar) antibody (ABIN7597491)

Target: PDL1 (Adebrelimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Grade: Research Grade

Product Details anti-PDL1 (Adebrelimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Adebrelimab Biosimilar Antibody

Specificity: B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for PDL1 (Adebrelimab Biosimilar)

Target: PDL1 (Adebrelimab Biosimilar)

Alternative Name: Adebrelimab Biosimilar

Target Type: Biosimilar

Background: B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274

UniProt: Q9NZQ7

CAS-No: 2247114-85-6